About Anthony Iafrate, MD, PhD

Dr. Iafrate is a Professor of Pathology at Harvard Medical School, former Director of the Center for Integrated Diagnostics (CID), a clinical laboratory for molecular diagnostics at Massachusetts General Hospital and is currently the Vice Chair of Academic Affairs at the Massachusetts General Hospital (MGH). Dr. Iafrate received his MD/PhD dual degree from the State University of New York at Stony Brook in 2000 and was trained in anatomic and molecular genetic pathology at Brigham and Women’s Hospital. Dr. Iafrate is a board-certified Pathologist and has been on staff at MGH since 2005. The CID provides rapid personalized genomic testing to help inform cancer treatment decisions for patients. His research is focused on lung and brain tumors, where he has been closely involved in the clinical development of crizotinib and companion diagnostics in ALK- and ROS1 positive lung cancers. His lab has developed several technologies for sequencing tumors, including SNaPshot and the next-generation sequencing-based Anchored Multiplex PCR, both techniques have been widely used in the molecular diagnostics community.

Clinical Interests:

Treats:

Locations

Pathology Associates
55 Fruit Street
Boston, MA 02114-2696
Fax: 617-726-7474

Medical Education

  • M.D.; Ph.D., S.U.N.Y. at Stony Brook, School of Medicine
  • MD, State University of New York, Stony Brook School of Medicine And Biomedical Sciences
  • Residency, Brigham and Women's Hospital
  • Fellowship, Brigham and Women's Hospital

American Board Certifications

  • Pathology, Unknown Board
  • Molecular Genetic Pathology, American Board of Medical Genetics
  • Anatomic Pathology, American Board of Pathology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Research in the Iafrate laboratory focuses on bringing new genetic technologies to cancer diagnostics and their application to the practice of pathology. Initially research focused on lung cancer, but our approach is expanding to all malignancies. For more information about research concepts, co-authors, and to see a timeline, visit  Dr. Iafrate's profile at the Harvard Clinical and Translational Science Center.

Publications